Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trials

BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been highly recommended for glycemic control and weight reduction. However, evidence has accumulated that GLP-1 RAs treatment is related to an increase in heart rate, which could potentially induce cardiac arrhythmias. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Sijin, Lu, Wenzhao, Chen, Zhongli, Dai, Yan, Chen, Keping, Zhang, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791739/
https://www.ncbi.nlm.nih.gov/pubmed/36572913
http://dx.doi.org/10.1186/s13098-022-00970-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791739/
https://www.ncbi.nlm.nih.gov/pubmed/36572913
http://dx.doi.org/10.1186/s13098-022-00970-2

Ejemplares similares